Press release
Radioligand Therapy Market Deep Research Report with Forecast to 2034
Global Radioligand Therapy Market 2025-2034 full Research Repot latest version is now available.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1281
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Radioligand Therapy market are:
• Increasing prevalence of cancer and neurological disorders driving the demand for targeted therapies.
• Advancements in radiopharmaceuticals and imaging technologies enhancing treatment precision and efficacy.
• Growing investment in research and development of novel radioligand therapies by biopharma companies.
The following are the primary obstacles to the Radioligand Therapy market's expansion:
• High cost of radioligand therapy limits accessibility and affordability for patients.
• Limited availability of specialized infrastructure and trained professionals for administering treatments.
• Regulatory challenges and long approval processes for new radioligand therapies delay market growth.
Future expansion opportunities for the global Radioligand Therapy market include:
• Growing demand for targeted cancer treatments drives opportunities in expanding radioligand therapy applications.
• Advancements in precision medicine and personalized treatment options enhance radioligand therapy adoption.
• Expansion into emerging markets with increasing healthcare investments and rising cancer incidences.
Key Industry Insights & Findings from the report:
• Radioligand therapy is gaining traction due to its targeted treatment approach for cancer.
• The market is experiencing growth driven by advancements in radiopharmaceuticals and personalized medicine.
• North America dominated the market and accounted for a revenue share of global revenue in 2023.
• One of the significant concerns restraining industry growth is the high treatment costs and limited reimbursement policies.
Market Analysis:
The radioligand therapy market is witnessing significant momentum, propelled by the evolution of precision medicine and a growing global cancer burden. These targeted therapies offer a promising approach by precisely delivering radiation to cancer cells, thereby minimizing harm to surrounding healthy tissue. This localized treatment method has contributed to their increasing adoption due to fewer side effects compared to traditional cancer therapies.
Substantial investments in research and development, along with supportive regulatory frameworks, are fostering innovation and accelerating the introduction of new radioligand treatments. Nevertheless, the high costs associated with these therapies and the need for advanced medical infrastructure and trained personnel pose notable challenges.
List of Prominent Players in the Radioligand Therapy Market:
• Clovis Oncology
• Curium Pharma
• Amneal Pharmaceuticals LLC
• Novartis AG
• Molecular Partners
• Pfizer Inc.
• Eli Lilly and Company (POINT Biopharma Global Inc.)
• Fusion Pharmaceuticals Inc.
• Telix Pharmaceuticals
• Lantheus Holdings Inc.
• Bayer AG
• ITM Isotope Technologies Munich SE
• Precirix
• Radio Medix
• Johnson & Johnson Services Inc.
Recent Developments:
• In May 2024, Novartis AG announced its agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts. Mariana Oncology specializes in developing innovative radioligand therapies (RLTs) aimed at addressing cancers with significant unmet patient needs.
• In May 2024, Bayer AG announced the start of a Phase I first-in-human clinical study for 225Ac-PSMA-Trillium, a next-generation targeted alpha therapy. This investigational drug labeled with actinium-225 and featuring a novel PSMA-targeting molecule with a customized albumin-binding moiety, aims to enhance therapeutic efficacy while minimizing side effects in normal organs such as salivary glands.
• In December 2023, Lantheus Holdings, Inc. and POINT Biopharma Global Inc. announced statistically significant topline results from the pivotal phase 3 SPLASH study evaluating the efficacy and safety of 177Lu-PNT2002, a prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT), in patients with metastatic castration-resistant prostate cancer (mCRPC) after progression on an androgen receptor pathway inhibitor (ARPI).
Radioligand Therapy Market Dynamics:
Market Drivers: Increasing Prevalence of Cancer and Neurological Disorders Driving the Demand for Targeted Therapies
Market Drivers: Surge in Cancer and Neurological Conditions Spurs Demand for Precision Therapies
The rising global incidence of cancer and neurological disorders is significantly boosting demand for precision-based treatments like radioligand therapy. This innovative approach involves delivering radioactive compounds directly to diseased cells, reducing harm to surrounding healthy tissue.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1281
Challenges: High Cost of Radioligand Therapy Limits Accessibility and Affordability for Patients
Despite its therapeutic potential, radioligand therapy faces major obstacles related to affordability and accessibility. The complex requirements of the therapy-including specialized infrastructure, high-end technology, and trained personnel-significantly drive up costs. This limits patient access, especially in economically challenged regions, and reduces the therapy's market reach.
North America Is Expected to Grow with the Highest CAGR During the Forecast Period
North America is expected to register the highest compound annual growth rate (CAGR) in the radioligand therapy market over the forecast period. The region's growth is propelled by rising cancer cases, robust investments in medical research, and a favorable environment for regulatory approvals and reimbursement. Increasing awareness of targeted oncology treatments, coupled with well-established healthcare infrastructure and a strong pipeline of clinical trials, positions North America as a dominant player in this evolving field.
Unlock Your GTM Strategy:
https://www.insightaceanalytic.com/customisation/1281
Segmentation of Radioligand Therapy Market-
By Isotope-
• Lutetium-177 (Lu-177)
• Actinium-225 (Ac-225)
• Iodine-131 (I-131)
• Other Isotopes
By Target-
• Prostate-Specific Membrane Antigen
• Ki 67 Expression and Grading
• Cytochrome P450 17A1 Inhibitor
By Indication-
• Prostate Cancer
• Neuroendocrine Tumours (NETs)
• Others
By End User-
• Hospitals
• Ambulatory Surgical Centers
• Cancer Treatment Centers
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get More Information :
https://www.insightaceanalytic.com/report/global-radioligand-therapy-market/1281
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 607 400-7072
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radioligand Therapy Market Deep Research Report with Forecast to 2034 here
News-ID: 4059528 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Aseptic Fill Finish Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Aseptic Fill Finish Market Size, Share & Trends Analysis Report By Molecules (Small Molecules & Biologics), Type of Packaging Containers (Ampoules, Cartridges, Syringes, and Vials), Drug Product Types (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines, and Other Products), Target Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases Oncological Disorders, and Other Disorders), Scale…
Biomedical Textiles Market Report on the Untapped Growth Opportunities in the In …
"Biomedical Textiles Market" in terms of revenue was estimated to be worth $15.07 billion in 2023 and is poised to reach $26.85 billion by 2031, growing at a CAGR of 7.69% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request For Free Sample Pages @
https://www.insightaceanalytic.com/request-sample/1480
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biomedical Textiles market are:
• Growth In Medical Expenditure
• Rapid Growth In…
Bio-LNG Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bio-LNG Market Size, Share & Trends Analysis Report By Application (Automotive, Ships, And Others), Source (Agriculture Residues, Industrial Waste, Household Waste, And Others), Region, Market Outlook And Industry Analysis 2034"
The global Bio-LNG Market is estimated to reach over USD 5133.3 Million by 2034, exhibiting a CAGR of 19.3% during the forecast period.
Request For…
Biocides Market Revenue Report with Forecast to 2034
"Biocides Market" in terms of revenue was estimated to be worth $ 9.50 billion in 2024 and is poised to reach $ 15.25 billion by 2034, growing at a CAGR of 5.0% from 2025 to 2034, according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1637
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biocides Market are:
• Growing Awareness of Hygiene and Health
• Expansion in…
More Releases for Radio
Global Radio Market 2020 iHeartMedia, Communicorp, Cumulus, Buckley Radio, UTV R …
Global Radio Industry Competitive Analysis - Forecast and Historical Market Analysis by Key Market Segments
The research report on the global Radio market encompasses a wide-scope analysis of various macro economic and micro economic factors affecting the industry performance on a regional and global level. The research report offers a detailed outline of the industry chain components including suppliers, customers, manufacturers, and distributors. Moreover, the report intends to offer important highlights…
Tactical Communication Market Segmented By Manpack radio, Handheld radio, Vehicu …
This Fact.MR Report examines global tactical communication market for the forecast period 2017–2026. The prime purpose of the report is to find opportunities and trends in the market and provide insights pertaining to segments of the global tactical communication market.
To understand the opportunities and trends in this market, the report is categorically divided into four sections namely on the basis of product type, platform, application, technology and region. The report…
Global Digital Two Way Radio Market 2017 : Conventional Radio System, Trunked Ra …
A market study based on the " Digital Two Way Radio Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Digital Two Way Radio Market 2017’. The research report analyses the historical as well as present performance of the worldwide Digital Two Way Radio industry, and makes predictions on the future status of Digital Two Way Radio market on the basis of this…
Uruguay Radio Live ( Online Radio )
Uruguay Live Radio is generated to accommodate our users’ expectations, who need some innovations as well as tendency to get acquainted with high-class devices.
The following application is compatible with iPhone, iPad and iPod touch meanwhile is very easy to use. This is a wireless telegraphy which broadcasts advanced Radio Stations available from all over the world.
Uruguay Live Radio is a free application which enables you to listen to…
Togo Radio Live ( Online Radio )
Togo Live Radio is created to meet our users’ demands and expectations. This innovative application is full of comprehensive Radio Stations, which are renewed and expanded from time to time by the smart individuals. The following app is free and provides you with an exclusive opportunity to listen to your favorite music and newsworthy programs, as well as news from diverse countries awing to its broadband connection.
Togo Live Radio…
Israel Radio Live ( Online Radio )
Israeli Live Radio is customized only for iPhone, iPad and iPod touch which is created to meet our users’ high demands. This online application is free and enables you to listen to Radio, news, diverse programs from any country you want, awing to its broadband connection. The following Israeli Live Radio with regular updates gives you an ideal opportunity to get acquainted with the latest news or programs.
This pioneering…
